Our team at LawFirm.com can no longer help with EzriCare cases.
Get helpful answers to top legal questions, instantly.
Our team at LawFirm.com can no longer help with EzriCare cases.
The Centers for Disease Control and Prevention (CDC) has linked Delsam Pharma® and EzriCare® Artificial Tears over-the-counter eye drops to drug-resistant eye infections. The bacterial infections have caused blindness in some people and several patients have died. An EzriCare Artificial Tears lawsuit can help affected individuals pursue financial compensation.
On Feb. 1, 2023, the CDC issued a Health Advisory concerning eye infections associated with using EzriCare Artificial Tears. The preservative-free lubricant eye drop is used to treat dry eye and is sold in multidose bottles by major retailers such as Walmart and Amazon.
Specifically, the CDC has identified 81 patients in 18 states with a type of antibiotic-resistant bacterial infection known as carbapenem-resistant Pseudomonas aeruginosa (CRPA). Sadly, 4 patients have died.
“Recent epidemiology and laboratory evidence link those infections to use of EzriCare Artificial Tears.”
— Centers for Disease Control and Prevention
The CDC said it has detected CRPA in opened bottles of EzriCare Artificial Tears.
The affected eye drops are:
On February 22, 2023, the FDA included Delsam Pharma’s Artificial Eye Ointment in its warning because of possible bacterial contamination.
The agency recommends that health care providers and consumers “immediately discontinue using EzriCare Artificial Tears.”
The U.S. Food & Drug Administration has issued a similar warning.
Additionally, Global Pharma Healthcare Private Limited, the product manufacturer, has initiated a voluntary product recall based on the FDA’s recommendation.
When a product harms innocent people, they may be able to take legal action and file a product liability lawsuit. For example, an EzriCare Artificial Tears lawsuit allows injured consumers to pursue financial compensation for medical bills, pain and suffering, and more and hold negligent drug companies accountable.
As of February 10, 2023, victims have started filing lawsuits related to EzriCare use.
People who have used EzriCare Artificial Tears are at risk of carbapenem-resistant Pseudomonas aeruginosa (CRPA), a type of bacterial infection resistant to a class of antibiotics known as carbapenems.
Pseudomonas is a type of bacteria commonly found in soil and water. Pseudomonas aeruginosa is the strain that is most likely to make people sick. It can cause infections in the blood, lungs, and other parts of the body.
CRPA in the eyes can cause eye infections such as:
Unfortunately, EzriCare is not the only brand of eye drops that poses a danger.
On October 27, 2023, the FDA warned consumers about more than two dozen other over-the-counter eye drops that could cause infection and lead to vision loss. FDA investigators found unsanitary conditions, including bacterial contamination, at the manufacturing facility.
These products are listed below by brand.
CVS Health:
Leader (Cardinal Health):
Rite Aid:
Rugby (Cardinal Health):
Target:
Velocity Pharma LLC:
Walmart:
In August 2023, the FDA issued a similar warning about two other brands of eye drops after finding evidence of bacterial and fungal contamination.
The FDA advises patients who experience eye infection symptoms after using any of the products listed above to seek immediate medical care.
People who have used EzriCare Artificial Tears should know the symptoms of a CRPA eye infection to protect their health.
Symptoms of CRPA eye infections often include:
Of the 81 patients the CDC is monitoring, the outcomes include:
Additionally, four patients have died after the bacterium invaded their bloodstream.
Patients with cataracts, glaucoma, and other eye conditions are most likely to experience vision loss and other serious eye issues. In addition, people with compromised immune systems are most at risk of life-threatening health problems.
People who have used EzriCare Artificial Tears but are not showing signs of infection do not need to get tested for CRPA, according to the CDC.
If you or a loved one are experiencing eye infection symptoms or other health issues after using Ezricare Artificial Tears eye drops, get medical attention as soon as possible.
Doctors treat CRPA eye infections with antibiotics in most cases.
Specifically, treatment options for CRPA eye infections may include:
The CDC notes that CRPA infections are becoming more challenging to treat because of increasing antibiotic resistance.
“For some multidrug-resistant types of Pseudomonas aeruginosa, treatment options might be limited.”
– Centers for Disease Control and Prevention
If your doctor instructed you to use EzriCare Artificial Tears, you should ask them about a different artificial tears eye drop to use.
EzriCare Artificial Tears eye drop users who have been harmed by this dangerous product have the right to seek compensation and justice.
In general, people eligible for an EzriCare Artificial Tears lawsuit are those who used EzriCare Artificial Tears Lubricant Eye Drops and later:
The first step in filing an EzriCare Artificial Tears Lawsuit is to partner with an experienced personal injury lawyer. The attorneys in our network that work on dangerous product cases have a proven track record of helping people like you across the United States.
These lawyers can handle your case from filing to resolution and have the resources to take on powerful drug companies. They charge no up-front or out of pocket costs — the law firms only get paid if they recover compensation for you.
Yes, most artificial tears are safe for use. However, the Centers for Disease Control and Prevention (CDC) on Feb. 1, 2023, issued a Health Advisory instructing consumers to immediately stop using EzriCare Artificial Tears because the eye drop has been linked to drug-resistant eye infections.
Other eye drops that pose a risk of infection include:
Eye drops sold under the brand name EzriCare Artificial Tears have been recalled. Global Pharma, the company that makes EzriCare Artificial Tears, issued the voluntary recall on Feb. 2, 2023, because of possible bacterial contamination.
The FDA suggested the recall based on Global Pharma’s violation of manufacturing regulations. For example, the agency said Global Pharma:
The FDA says these eyedrops pose similar risks:
Global Pharma Healthcare Private Limited manufactures EzriCare Artificial Tears in India. The product is distributed in the United States by Aru Pharma Inc. and Delsam Pharma.
On Feb. 2, 2023, the company voluntarily recalled the product, saying in its risk statement that use of EzriCare Artificial Tears “can result in the risk of eye infections that could result in blindness.”
CRPA is short for carbapenem-resistant Pseudomonas aeruginosa, a strain of bacteria resistant to standard antibiotics. So far, the CDC has identified 81 patients in 18 states with the infection.
Most of the patients reported using EzriCare Artificial Tears — a preservative-free eye drop used to treat dry eye — before they became sick. The manufacturer has recalled the product.
Fact-Checked and Legally Reviewed by: LawFirm.com
LawFirm.com makes it easier to take legal action. We have information, lawsuit guides, and breaking news about drugs, products, and other issues that could affect you.